We are monitoring the impact of COVID-19 on Asia Pacific Renal Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5225
Share on
Share on

Asia Pacific Renal Biomarkers Market Research Report - Segmented By Diagnostic Technique, Type & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 5225
Pages: 145

Asia Pacific Renal Biomarkers Market Size & Growth (2019 – 2024):

The Asia Pacific Renal Biomarkers  Market is worth USD xx million in 2018 and estimated to grow at a CAGR of xx.x%, to reach USD xx million by 2024 during the forecast period 2019-2024.

A Renal Biomarkers indicates the presence of kidney diseases by measuring blood or urine levels. Kidney diseases are one of the main reasons for death around the world.  The incidence of Chronic kidney diseases have increased due to factors like diabetes and hypertension. Advancements in technology have led to the introduction of renal biomarker which detects kidney problems accurately.

The significant drivers are rising population with kidney problems, growing incidence of renal diseases, increasing geriatric population and increasing incidence of diseases like high blood pressure and diabetes. Advancements in technology is also expected to drive the market over the forecast period. Reimbursement issues are major restraints limiting this industry.

Asia Pacific Renal Biomarkers Market has been segmented and sub-segmented into the following categories

  • By Diagnostic Technique: Chemiluminescent Enzyme Immunoassay, Colorimetric Assay, Enzyme-Linked Immunosorbent Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay
  • By Type: Up-Regulated Proteins, Interleukin 18, Kidney injury molecule 1, Neutrophil gelatinase-associated lipocalin, Functional Biomarker, Serum Creatinine, Serum Cystatin C, Urine Albumin.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

Top Companies dominating the Asia Pacific Renal Biomarkers Market Profiled in the Report are Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Astute Medical Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Alere Inc., bioMérieux SA, and Randox Laboratories Ltd.,

1. Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Diagnostic Technique    

       5.1.1 Introduction           

       5.1.2 Chemiluminescent Enzyme Immunoassay

       5.1.3 Colorimetric Assay               

       5.1.4 Enzyme-Linked Immunosorbent Assay       

       5.1.5 Liquid Chromatography-Mass Spectrometry            

       5.1.6 Particle-Enhanced Turbidimetric Immunoassay      

       5.1.7  Y-o-Y Growth Analysis, By Diagnostic Technique   

       5.1.8  Market Attractiveness Analysis, By Diagnostic Technique

       5.1.9  Market Share Analysis, By Diagnostic Technique   

                5.2 Type     

       5.2.1 Introduction           

       5.2.2 Up-Regulated Proteins      

                       5.2.2.1 Interleukin 18

                       5.2.2.2 Kidney injury molecule 1

                       5.2.2.3 Neutrophil gelatinase-associated lipocalin

       5.2.3 Functional Biomarker         

                       5.2.3.1 Serum Creatinine

                       5.2.3.2 Serum Cystatin C

                       5.2.3.3 Urine Albumin

       5.2.4 Others      

       5.2.5 Y-o-Y Growth Analysis, By Type     

       5.2.6 Market Attractiveness Analysis, By Type   

       5.2.7 Market Share Analysis, By Type     

                5.3 End User                      

       5.3.1 Introduction           

       5.3.2 Diagnostic Labs      

       5.3.3 Hospitals  

       5.3.4 Outpatient Clinics 

       5.3.5 Research Centres 

       5.3.6 Y-o-Y Growth Analysis, By End User             

       5.3.7  Market Attractiveness Analysis, By End User          

       5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Diagnostic Technique

                       6.1.3.3 By Type

                       6.1.3.4 By End User

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Diagnostic Technique

                       6.1.4.3 By Type

                       6.1.4.4 By End User

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Diagnostic Technique

                       6.1.5.3 By Type

                       6.1.5.4 By End User

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia       

                6.7 Rest of APAC               

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 Thermo Fisher Scientific Inc                 

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Abbott Laboratories      

                8.3 Beckman Coulter, Inc.   

                8.4 Randox Laboratories Ltd                       

                8.5 Astute Medical Inc.                 

                8.6 F. Hoffmann-La Roche AG                    

                8.7 Siemens Healthcare Diagnostics Inc.                

                8.8 Alere Inc.                     

                8.9 bioMérieux SA

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms Diagnostic Technique and Type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Renal Biomarker Market By Diagnostic Technique, From 2019-2024 ( USD Million )
  2. Asia Pacific Enzyme-Linked Immunosorbent Assay Market By Region, From 2019-2024 ( USD Million )
  3. Asia Pacific Chemiluminescent Enzyme Immunoassay Market By Region, From 2019-2024 ( USD Million )
  4. Asia Pacific Colorimetric Assay Market By Region, From 2019-2024 ( USD Million )
  5. Asia Pacific Liquid Chromatography-Mass Spectrometry Market By Region, From 2019-2024 ( USD Million )
  6. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market By Region, From 2019-2024 ( USD Million )
  7. Asia Pacific Renal Biomarker Market By Biomarker Type, From 2019-2024 ( USD Million )
  8. Asia Pacific Up-Regulated Proteins Market By Region, From 2019-2024 ( USD Million )
  9. Asia Pacific Functional Biomarker Market By Region, From 2019-2024 ( USD Million )
  10. Asia Pacific Renal Biomarker Market By End User, From 2019-2024 ( USD Million )
  11. Asia Pacific Diagnostic Labs Market By Region, From 2019-2024 ( USD Million )
  12. Asia Pacific Hospitals Market By Region, From 2019-2024 ( USD Million )
  13. Asia Pacific Outpatient Clinics Market By Region, From 2019-2024 ( USD Million )
  14. Asia Pacific Research Centres Market By Region, From 2019-2024 ( USD Million )
  15. Japan Renal Biomarker Market By Diagnostic Technique, From 2019-2024 ( USD Million )
  16. Japan Renal Biomarker Market By Biomarker Type, From 2019-2024 ( USD Million )
  17. Japan Renal Biomarker Market By End User, From 2019-2024 ( USD Million )
  18. China Renal Biomarker Market By Diagnostic Technique, From 2019-2024 ( USD Million )
  19. China Renal Biomarker Market By Biomarker Type, From 2019-2024 ( USD Million )
  20. China Renal Biomarker Market By End User, From 2019-2024 ( USD Million )
  21. India Renal Biomarker Market By Diagnostic Technique, From 2019-2024 ( USD Million )
  22. India Renal Biomarker Market By Biomarker Type, From 2019-2024 ( USD Million )
  23. India Renal Biomarker Market By End User, From 2019-2024 ( USD Million )
  24. Australia Renal Biomarker Market By Diagnostic Technique, From 2019-2024 ( USD Million )
  25. Australia Renal Biomarker Market By Biomarker Type, From 2019-2024 ( USD Million )
  26. Australia Renal Biomarker Market By End User, From 2019-2024 ( USD Million )
  27. South Korea Renal Biomarker Market By Diagnostic Technique, From 2019-2024 ( USD Million )
  28. South Korea Renal Biomarker Market By Biomarker Type, From 2019-2024 ( USD Million )
  29. South Korea Renal Biomarker Market By End User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample